Replacement of Therapix Biosciences of its board of directors

Itschak Shrem has been appointed chairman of the new Board of Directors and Amitay Weiss, in addition to his membership in the board, will hold the position of CEO of the Company.

“I’m very happy to settle for duty and look forward to taking the company in an exciting new direction,” said Itchak Shrem, the company’s new president. “Under the new leadership, I am confident that the company will, however, maximize its impressive outlook while providing a deserved return to our shareholders,” he continued.

Leave a Comment

Your email address will not be published. Required fields are marked *